Wednesday, March 4, 2009

Birthday: Iteration Two.

III.

It is anything
which you can't get
till the second Ph1 world study
of Gemcitabine/Erlotinib/MK
which 0646 undergoes
for a patient having impossible
worse pancreatic cancer.

The reason why doesn't have poetry
to people whom it takes with it,
have a blade or it often breaks through
for the foolishness that it is.

It easily is sharp or must be detained
carefully right after you need it anatomically.

No comments:

Post a Comment